Search

Your search keyword '"Al-Jardani A."' showing total 249 results

Search Constraints

Start Over You searched for: Author "Al-Jardani A." Remove constraint Author: "Al-Jardani A."
249 results on '"Al-Jardani A."'

Search Results

207. The first glycopeptide-intermediate Staphylococcus aureus in Oman

209. Effects of pesticide temephos on the gills of Aphanius dispar (Pisces: Cyprinodontidae).

210. Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumanniiIsolates in the Gulf Cooperation Council States: Dominance of OXA-23-Type Producers

211. Molecular Characterization of Carbapenemase-Producing Escherichia coliand Klebsiella pneumoniaein the Countries of the Gulf Cooperation Council: Dominance of OXA-48 and NDM Producers

213. Screening migrants from tuberculosis high-endemic countries for latent tuberculosis in Oman: A cross sectional cohort analysis.

214. Screening for latent tuberculosis in migrants—status quo and future challenges.

215. Hypervirulent Capsular Serotypes K1 and K2 Klebsiella pneumoniae Strains Demonstrate Resistance to Serum Bactericidal Activity and Galleria mellonella Lethality.

216. Recurrent Infective Endocarditis in an Adolescent due to Streptococcus agalactiae: A Rare Presentation of a Common Pathogen.

217. Imported Case of Melioidosis in Oman: Case Report.

218. Evaluation of Four Rapid Antigen Tests for Detection of SARS-CoV-2 virus.

219. The role of supporting services in driving SARS-CoV-2 transmission within healthcare settings: A multicenter seroprevalence study.

220. Epidemiological Characteristics of Pandemic Coronavirus Disease (COVID-19) in Oman.

221. Molecular epidemiology of COVID-19 in Oman: A molecular and surveillance study for the early transmission of COVID-19 in the country.

222. Effects of COVID-19 on mortality: A 5-year population-based study in Oman.

223. COVID-19 epidemic monitoring after non-pharmaceutical interventions: The use of time-varying reproduction number in a country with a large migrant population.

224. Tools to implement the World Health Organization End TB Strategy: Addressing common challenges in high and low endemic countries.

225. Control of the 2018–2019 dengue fever outbreak in Oman: A country previously without local transmission.

226. Pertussis and Pertussis like Illness: Pediatric Experience in Oman.

227. Latent Tuberculosis in Health Care Workers Exposed to Active Tuberculosis in a Tertiary Care Hospital in Oman.

228. The Rising Threat of Mucormycosis: Oman's Experience Before and During the COVID-19 Pandemic.

229. Time trend of respiratory viruses before and during the COVID-19 pandemic in severe acute respiratory virus infection in the Sultanate of Oman between 2017 and 2022.

230. The Seroprevalence of Hepatitis C Virus (HCV) in Hemodialysis Patients in Oman: A National Cross-Sectional Study.

231. Mycobacterium tuberculosis epidemiology in Oman: whole-genome sequencing uncovers transmission pathways.

232. Genomic and geospatial epidemiology of Mycobacterium tuberculosis in Oman: first national insight using whole genome sequencing.

233. External quality assessment of laboratory performance in bacteriology in the Eastern Mediterranean Region, 2011-2019.

234. Genomic analysis of the emerging carbapenem-resistant Klebsiella pneumoniae sequence type 11 harbouring Klebsiella pneumoniae carbapenemase (KPC) in Oman.

235. Prevalence of Hepatitis B Infection Among Pregnant Women in Oman.

236. Drug resistant Mycobacterium tuberculosis in Oman: resistance-conferring mutations and lineage diversity.

237. Dynamics of Mycobacterium tuberculosis Lineages in Oman, 2009 to 2018.

238. PulseNet International Survey on the Implementation of Whole Genome Sequencing in Low and Middle-Income Countries for Foodborne Disease Surveillance.

239. Burkholderia pseudomallei Septic Arthritis of the Knee Joint: Report of a Third Imported Case in Oman.

241. Challenges and Opportunities for Public Health Service in Oman From the COVID-19 Pandemic: Learning Lessons for a Better Future.

242. The role of children and adolescents in the transmission of SARS-CoV-2 virus within family clusters: A large population study from Oman.

243. Seroprevalence of SARS-CoV-2 antibodies in the general population of Oman: results from four successive nationwide sero-epidemiological surveys.

244. Genomic analysis of the first cases of extensively drug-resistant, travel-related Salmonella enterica serovar Typhi in Oman.

245. Serotype distribution and antibiotic resistance among invasive Streptococcus pneumoniae from Oman post 13-valent vaccine introduction.

246. Epidemiology of Meningitis in Oman-Implications for Future Surveillance.

247. Rates of catheter-associated urinary tract infection in tertiary care hospitals in 3 Arabian Gulf countries: A 6-year surveillance study.

248. Ventilator-associated pneumonia rates in critical care units in 3 Arabian Gulf countries: A 6-year surveillance study.

249. Hospitalised patients with Influenza A (H1N1) in the Royal Hospital, Oman: Experience of a tertiary care hospital, July-December 2009.

Catalog

Books, media, physical & digital resources